Abstract:Transcatheter tricuspid valve interventions (TTVI) are emerging as alternatives to surgery in high-risk patients with isolated or concomitant tricuspid regurgitation. The development of new minimally invasive solutions potentially more adapted to this largely undertreated population of patients, has fuelled the interest for the tricuspid valve. Growing evidence and new concepts have contributed to revise obsolete and misleading perceptions around the right side of the heart. New definitions, classifications, and a better understanding of the disease pathophysiology and phenotypes, as well as their associated patient journeys have profoundly and durably changed the landscape of tricuspid disease. A number of registries and a recent randomized controlled pivotal trial provide preliminary guidance for decision-making. TTVI seem to be very safe and effective in selected patients, although clinical benefits beyond improved quality of life remain to be demonstrated. Even if more efforts are needed, increased disease awareness is gaining momentum in the community and supports the establishment of dedicated expert valve centres. This review is summarizing the achievements in the field and provides perspectives for a less invasive management of a no-more-forgotten disease. Disease stage and therapeutic strategies for tricuspid regurgitation. Tricuspid regurgitation evolves from undetectable early forms to advanced stages characterized by escalating symptoms, right heart failure, and organ impairment. While medical therapy is utilized throughout the disease course, its effectiveness wanes with progression. Surgery can play a role in the earlier stages, while transcatheter therapies are available for patients at high risk and in the more advanced stages of disease. Significant overlap between treatment options underscores the urgent need for precise, evidence-based protocols. Overall, early intervention is crucial to prevent organ damage and avoid futility of late treatments (smileys becoming sad). CAVI, caval valve implantation; RHF, right heart failure; TR, tricuspid regurgitation; RA, right atrial; RV, right ventricular; TTV, transcatheter tricuspid valve.

Pacing and Defibrillation Consideration in the Era of Transcatheter Tricuspid Valve Replacement

Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation: JACC State-of-the-Art Review

Tricuspid Valve Replacement in a Patient with a Leadless Cardiac Pacemaker: Current Guidelines and Recommendations for Perioperative Management

Permutations in pacer wire implantation in patients evaluated for transcatheter tricuspid valve interventions

Tricuspid Regurgitation Following Implantation of a Pacemaker/Cardioverter-Defibrillator

Transcatheter tricuspid valve intervention in the presence of a cardiac implantable electronic device; state of the art review

Implantable cardioverter‐defibrillator lead failure and revision following transcutaneous bicaval valve (TricValve®) implantation

Transcatheter Tricuspid Valve-in-Valve Intervention for Degenerative Bioprosthetic Tricuspid Valve Disease.

The Current Landscape of Transcatheter Tricuspid Valve Intervention

Transcatheter tricuspid valve interventions: Current status and future perspectives

Tricuspid Valve Incompetence Following Implantation of Ventricular Leads

Update on Transcatheter Tricuspid Valve Replacement Therapies

Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leads

Transcatheter tricuspid valve intervention: a practical algorithm for patient selection

Tricuspid valve disease and cardiac implantable electronic devices

Functional Tricuspid Regurgitation in the Transcatheter Aortic Valve Replacement Population and Emerging Transcatheter Tricuspid Valve Interventions

New therapeutic approach for tricuspid regurgitation: Transcatheter tricuspid valve replacement or repair

Single-chamber atrial pacing + Micra AV implantation: A case report

Transcatheter treatment of the tricuspid valve: current status and perspectives

Percutaneous Tricuspid Valve Repair: The Triclip

Valvular Heart Failure due to Tricuspid Regurgitation: Surgical and Transcatheter Management Options